Evidence map›Paper›PMID 36272112›Full record

ArticleHealth services research2023

Association between hospital-physician vertical integration and medication adherence rates.

Jonathan S Levin, Swad Komanduri, Christopher Whaley

Open access · hybridAbstract read
In one paragraph

Article in Health services research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jonathan S LevinRAND Health Care, RAND Corporation, Arlington, Virginia, USA.ORCID 0000-0002-0205-2053
Swad KomanduriRAND Health Care, RAND Corporation, Santa Monica, California, USA.
Christopher WhaleyRAND Health Care, RAND Corporation, Santa Monica, California, USA.ORCID 0000-0002-9405-1989
RAND Corporation · US

Funding

Understanding Health Care Delivery Systems PCOR Adoption and System PerformanceU19HS024067 · AHRQ · RAND CORPORATION · PI DAMBERG, CHERYL · 2015 to 2019
$17.4M
The Effects of Insurance Benefit Design Innovation on Patient HealthK01AG061274 · NIA · RAND CORPORATION · PI WHALEY, CHRISTOPHER · 2019 to 2023
$649k
AHRQ HHS U19 HS024067NIA NIH HHS K01 AG061274
6 · The paper itself

Abstract

objectiveTo test the association between vertical integration of primary care providers (PCPs) and adherence rates for anti-diabetics, renin angiotensin system antagonists (RASA), and statins. DATA SOURCES: Medicare Part B outpatient fee-for-service claims and Medicare Part D event data from 2014 to 2017. STUDY

designWe estimated difference-in-differences regressions, comparing changes in adherence among patients with PCPs who converted from independent to integrated to changes among patients whose PCPs remained independent or integrated during the study period. To test for heterogenous impacts by patient demographics, we estimated triple difference regressions that included additional interaction terms by comorbidity rates, age group, and race/ethnicity. EXTRACTION

methodsWe extracted Medicare claims for adults with continuous enrollment in Parts B and D during the study period. PRINCIPAL

findingsThe proportion of patients who had a vertically integrated PCP increased by approximately 23% over the study period. Changes in adherence did not differ significantly between patients based on whether their PCP became integrated (Statins: 0.18, 95% CI -0.13, 0.49; RASA: -0.13, 95% CI -0.46, 0.19; Anti-Diabetics: -0.20, 95% CI -0.78, 0.38). Among patients with PCPs who became integrated, there were significant decreases in adherence for patients who were Black, Asian, Hispanic, or Native American, above 80 years old, and had greater comorbidities for all three classes.

conclusionsWhile there were no average changes in adherence following vertical integration of PCPs, health equity worsened, with significant declines in adherence for Black, Asian, Hispanic, and Native American patients, patients over 80 years old, and patients with greater comorbidities. These findings suggest that integration may reduce clinicians' incentives to compete based on the quality of care delivered. Given the price increases associated with integration, integration may be a net welfare loss.

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsMedicare Part DPhysiciansAdultAgedAged, 80 and overHumansHypoglycemic AgentsMedication AdherenceUnited StatesHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic Agentshealth equityhospitalsMedicare Part Dmedication adherencephysiciansprimary care

Identifiers

PMID36272112
PMCPMC10012217
OpenAlexW4307091933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.